Hybrid CAR-T Cell Data for HIV Suppression in Humanized Mice

A 3.1 MB document authored by Zoe Stylianidou and last updated in May 2026. It describes a preclinical study evaluating a Hybrid chimeric antigen receptor (CAR) platform combining CAR-T cell cytotoxicity with broadly neutralizing antibody secretion. The research reports in vitro results and a more than 9-fold reduction in plasma viremia in humanized mice.

Use Cases

• Analyzing the antiviral mechanisms of dual-function immunotherapies based on the described combination of cellular and humoral immunity.
• Benchmarking preclinical efficacy metrics for HIV treatments based on the reported reduction in plasma and tissue viral levels.
• Studying Fc-mediated effector functions like ADCC and ADCP based on the in vitro activity described for the secreted antibodies.

Strengths

• Includes specific quantitative results, such as a more than 9-fold reduction in plasma viremia.
• Describes a clear, dual-function platform combining CAR-T cells and antibody secretion.
• Released under a permissive CC-BY-4.0 license.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The 3.1 MB file size suggests a small-scale document rather than a large dataset.

Provenance

Source

figshare

Collection Method

Likely contains experimental results from a preclinical research study.

Time Range

null

Freshness

Last updated 2026-05-08 05:54:04; freshness should be verified.

Geography

null